Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00257543 · ClinicalTrials.gov registry record · Early Phase 1
SALT: Alternative Donor Bone Marrow and Cord Blood Transplantation for High Risk Sickle Cell Disease
A Early Phase 1 study, sponsored by Emory University.
- Terminated
- Registry status
- Early Phase 1
- Development phase
- 3
- Enrollment target
NCT00257543 is a Early Phase 1 study that was terminated before completion, run by Emory University. The registered enrollment target is 3 participants.
The verdict
NCT00257543, a Early Phase 1 study, was terminated before completion, sponsored by Emory University.
- TERMINATED
- Registry status
- Early Phase 1
- Development phase
- 3 participants
- Enrollment target
Study Summary
We hope to gain valuable information about the safety, success of engraftment, and rates of complications using alternate donor transplantation for children with severe SCD. Crucial information will be also collected about late effects from alternate donor BMT sickle cell, providing valuable information to clinicians and families making decisions among interventions for children with severe sickle cell disease. If successful, alternate donor transplantation in this setting could pave the way to offering curative treatment to many more patients with severe SCD.
Interventions
- PROCEDURE Alternative donor bone marrow and cord blood
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 3 participants |
| Start Date | 2006-01 |
| Est. Completion | 2012-08 |
| Phase | Early Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00257543
The ClinicalTrials.gov registry entry for NCT00257543 describes a study currently listed as terminated, categorized as Early Phase 1. The registered enrollment target is 3 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Emory University, which has 1,208 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Alternative donor bone marrow and cord blood is the first listed.
NCT00257543 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00257543 about?
NCT00257543 is a clinical study titled "SALT: Alternative Donor Bone Marrow and Cord Blood Transplantation for High Risk Sickle Cell Disease". We hope to gain valuable information about the safety, success of engraftment, and rates of complications using alternate donor transplantation for children with severe SCD. Crucial information will be also collected about late effects from alternate donor BMT sickle cell, providing valuable informa...
What is the current status of trial NCT00257543?
This trial is currently terminated. It is a Early Phase 1 study. The enrollment target is 3 participants. The study started on 2006-01. Estimated completion is 2012-08.
What interventions are being tested in trial NCT00257543?
The interventions under investigation include: Alternative donor bone marrow and cord blood (PROCEDURE).
Who is sponsoring clinical trial NCT00257543?
This trial is sponsored by Emory University, which has 1,208 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.